Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
VECO Corporate Funding from Grez-Doiceau, company number BE0541622462, closed financial year 2025 with a result of € -2,560 after tax. For that financial year VECO Corporate Funding recorded a gross margin of € -43,972 and equity of € 1 million. Compared with financial year 2024, the result moved from € -958 to € -2,560. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 1 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -2,560
▼ 167 % more loss than in 2024
Profit after tax over the fiscal year.
€ 3,002
▼ 94% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -45,752.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,413
▲ 29% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -39,700 | € -33,909 | € -42,417 | € -43,972 | ▼ € 1,555 |
| Profit after taxes | € 1,878 | € 7,553 | € -958 | € -2,560 | ▼ € 1,602 |
| Equity | € 1,025,212 | € 1,032,765 | € 1,031,807 | € 1,029,248 | |
| Total debts | € 0 | € 4,235 | € 1,097 | € 1,413 | ▲ 29% |
| Cash | € 40,213 | € 9,341 | € 47,905 | € 3,002 | ▼ 94% |
| Retained profit | € -49,788 | € -42,235 | € -43,193 | € -45,752 | ▼ € 2,560 |
| Balance sheet total | € 1,025,212 | € 1,037,000 | € 1,032,904 | € 1,030,661 |
Key figures of VECO Corporate Funding, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to VECO Corporate Funding?
What happened at VECO Corporate Funding in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Eric LEBOSSE de LANNOY stepped down as director. NBB
- 4P MANAGEMENT SA stepped down as director. NBB
- Vincent LANGLADE stepped down as director. NBB
- Olivier PAUL stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2,560. Source: NBB ↗
- Eric LEBOSSE de LANNOY became a director. NBB
- 4P MANAGEMENT SA became a director. NBB
- Vincent LANGLADE became a director. NBB
In short
From € 1,878 profit in 2022 to € 2,560 loss in 2025.
Paid € 1 in corporate taxes since 2022.
Best year ever: 2023, with € 7,553 profit.
Management
The stake of 4P MANAGEMENT comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
VECO Corporate FundingThe shares are held by 4P MANAGEMENT (19.8%). It owns 100% of EMA PHARMACEUTICALS SAS itself.
Directors
According to the 2025 annual accounts
since 2025 · until 2030
Managing director · represented by Claude DEDRY
since 2025 · until 2030
Vincent LANGLADE
Director
since 2025 · until 2030
since 2025 · until 2030
Shareholders
19.8%
Participations
EMA PHARMACEUTICALS SAS
100%
Establishments
Establishment units
Physical locations of this company
Rue des Merisiers 12
1390 Grez-Doiceau
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0541.622.462
- VAT number
- BE 0541.622.462
- Registered office
- Rue des Merisiers 12, 1390 Grez-Doiceau
- Names & denominations
- VECO Corporate Funding
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 October 2013
- Peppol
- Not registered